DFFN Diffusion Pharmaceuticals Inc

Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy.

$6.97
As of 06/28/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/11/2005
Outstanding shares:  2,038,592
Average volume:  44,111
Market cap:   $14,086,671
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BD0YGB5
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.40
PS ratio:   0.00
Return on equity:   -14,862,785.43%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy